6 research outputs found

    The usefulness of C-reactive protein in predicting malaria parasitemia in a sub-Saharan African region.

    Get PDF
    BACKGROUND: Malaria remains a leading cause of childhood mortality in sub-Saharan Africa. Identifying patients who are at risk for severe manifestations at presentation still remains challenging. This study examines whether a semi-quantitative test on C-Reactive Protein (CRP) could be useful for rapidly predicting the presence or absence of malarial parasitemia in febrile children. METHOD: Data were collected from children with fever or a history of fever at the Agogo Presbyterian Hospital in the Ashanti Region of Ghana. Haematological measurements, microscopic detection of plasmodium species and semi-quantitative CRP measurements with a membrane-based immunoassay for whole blood were performed. CRP was classified as positive when the measured level was ≥ 10 mg/l. RESULTS: During 548 visits, thick blood film results could be obtained from 541 patients, 270 (49.3%) yielded parasitemia with Plasmodium spp. Whereas malaria parasites were detected in only a few patients (7.1%) with normal CRP levels (< 10mg/l), more than a half of patients with an increased CRP concentration (≥ 10 mg/l) were parasite positive (OR 14.5 [CI 4.4-47.6], p<0.001). Patients with increased CRP levels had more than an eight-fold likelihood for parasitemia after correction for other parameters (adjusted OR 8.7 [CI 2.5-30.5], p<0.001). Sensitivity, specificity as well as positive predictive and negative predictive values of CRP for malaria were 99.3% (CI 96.2%-100%), 9.2% (CI 6.4%-12.8%), 31.7% (CI 27.4%-36.1%) and 97.0% (CI 84.2%-99.9%), respectively. CONCLUSION: The semi-quantitative method of measuring CRP is cheap, rapid and easy to perform but not useful in predicting parasitemia and malaria. However, due to its high negative predictive value, it could have a role in identifying those patients unlikely to be presenting with clinical malaria

    Gonorrhö mit einem high-level-Azithromycin-resistenten Erreger in Deutschland

    Get PDF
    Das Epidemiologische Bulletin 32/33 2019 berichtet über eine urogenitale Gonorrhö bei einem 42-jährigen Patienten mit einem high-level-Azithromycin-resistenten N. gonorrhoeae-Stamm. Die Erkrankung wurde Ende Juni 2019 in Deutschland diagnostiziert. Eine Reiseanamnese beim Patienten bestand nicht, ebenso keine Vorerkrankungen und keine relevanten vorherigen Antibiotikatherapien. Die Partnerin des Patienten war ebenfalls erkrankt. Bei ihr wurde eine Gonorrhö sowohl endozervikal als auch pharyngeal nachgewiesen.Peer Reviewe
    corecore